Global Ketorolac Injection Competitive Landscape Professional Research Report 2025
Description
Global Ketorolac Injection Competitive Landscape Professional Research Report 2025
Research Summary
Ketorolac injection is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term relief of moderate to severe pain. It is often administered intramuscularly or intravenously in hospital or clinical settings. Ketorolac works by inhibiting the production of prostaglandins, which are chemicals involved in inflammation. This medication is particularly useful in situations where oral administration may not be feasible, and rapid pain relief is required, such as postoperative pain, kidney stone pain, or pain related to certain medical procedures. While ketorolac injection provides effective pain management, it is essential to use it for the shortest duration possible due to the potential risks associated with NSAIDs, including gastrointestinal bleeding and kidney problems. As with any medication, it should be prescribed and administered under the guidance of a healthcare professional.
According to DIResearch's in-depth investigation and research, the global Ketorolac Injection market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ketorolac Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ketorolac Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Ketorolac Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ketorolac Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ketorolac Injection Include:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Ketorolac Injection Product Segment Include:
Ketorolac Injection 15mg/ml
Ketorolac Injection 30mg/ml
Ketorolac Injection Product Application Include:
Hospital
Clinics
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Ketorolac Injection Industry PESTEL Analysis
Chapter 3: Global Ketorolac Injection Industry Porter’s Five Forces Analysis
Chapter 4: Global Ketorolac Injection Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Ketorolac Injection Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Ketorolac Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Ketorolac Injection Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Ketorolac Injection Product by Type
- 1.2.1 Ketorolac Injection 15mg/ml
- 1.2.2 Ketorolac Injection 30mg/ml
- 1.3 Ketorolac Injection Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinics
- 1.3.3 Others
- 1.4 Global Ketorolac Injection Market Revenue and Sales Analysis
- 1.4.1 Global Ketorolac Injection Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Ketorolac Injection Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Ketorolac Injection Market Sales Price Trend Analysis (2020-2032)
- 1.5 Ketorolac Injection Industry Trends and Innovation
- 1.5.1 Ketorolac Injection Industry Trends and Innovation
- 1.5.2 Ketorolac Injection Market Drivers and Challenges
- 2 Ketorolac Injection Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Ketorolac Injection Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Ketorolac Injection Market Analysis by Regions
- 4.1 Ketorolac Injection Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Ketorolac Injection Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Ketorolac Injection Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Ketorolac Injection Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Ketorolac Injection Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Ketorolac Injection Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Ketorolac Injection Sales Forecast by Region (2026-2032)
- 4.4 Global Ketorolac Injection Sales Price Trend Analysis (2020-2032)
- 5 Global Ketorolac Injection Market Size by Type and Application
- 5.1 Global Ketorolac Injection Market Size by Type
- 5.1.1 Global Ketorolac Injection Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Ketorolac Injection Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Ketorolac Injection Market Size by Application
- 5.2.1 Global Ketorolac Injection Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Ketorolac Injection Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Ketorolac Injection Market Size by Type
- 6.3.1 North America Ketorolac Injection Sales by Type (2020-2032)
- 6.3.2 North America Ketorolac Injection Revenue by Type (2020-2032)
- 6.4 North America Ketorolac Injection Market Size by Application
- 6.4.1 North America Ketorolac Injection Sales by Application (2020-2032)
- 6.4.2 North America Ketorolac Injection Revenue by Application (2020-2032)
- 6.5 North America Ketorolac Injection Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Ketorolac Injection Market Size by Type
- 7.3.1 Europe Ketorolac Injection Sales by Type (2020-2032)
- 7.3.2 Europe Ketorolac Injection Revenue by Type (2020-2032)
- 7.4 Europe Ketorolac Injection Market Size by Application
- 7.4.1 Europe Ketorolac Injection Sales by Application (2020-2032)
- 7.4.2 Europe Ketorolac Injection Revenue by Application (2020-2032)
- 7.5 Europe Ketorolac Injection Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Ketorolac Injection Market Size by Type
- 8.3.1 China Ketorolac Injection Sales by Type (2020-2032)
- 8.3.2 China Ketorolac Injection Revenue by Type (2020-2032)
- 8.4 China Ketorolac Injection Market Size by Application
- 8.4.1 China Ketorolac Injection Sales by Application (2020-2032)
- 8.4.2 China Ketorolac Injection Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Ketorolac Injection Market Size by Type
- 9.3.1 APAC (excl. China) Ketorolac Injection Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Ketorolac Injection Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Ketorolac Injection Market Size by Application
- 9.4.1 APAC (excl. China) Ketorolac Injection Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Ketorolac Injection Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Ketorolac Injection Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Ketorolac Injection Market Size by Type
- 10.3.1 Latin America Ketorolac Injection Sales by Type (2020-2032)
- 10.3.2 Latin America Ketorolac Injection Revenue by Type (2020-2032)
- 10.4 Latin America Ketorolac Injection Market Size by Application
- 10.4.1 Latin America Ketorolac Injection Sales by Application (2020-2032)
- 10.4.2 Latin America Ketorolac Injection Revenue by Application (2020-2032)
- 10.5 Latin America Ketorolac Injection Market Size by Country
- 10.6 Latin America Ketorolac Injection Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Ketorolac Injection Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Ketorolac Injection Market Size by Type
- 11.3.1 Middle East & Africa Ketorolac Injection Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Ketorolac Injection Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Ketorolac Injection Market Size by Application
- 11.4.1 Middle East & Africa Ketorolac Injection Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Ketorolac Injection Revenue by Application (2020-2032)
- 11.5 Middle East Ketorolac Injection Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Ketorolac Injection Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Ketorolac Injection Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Ketorolac Injection Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Ketorolac Injection Average Sales Price by Manufacturers (2021-2025)
- 12.2 Ketorolac Injection Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Ketorolac Injection Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Pfizer
- 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Pfizer Ketorolac Injection Product Portfolio
- 13.1.3 Pfizer Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Fresenius Kabi
- 13.2.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Fresenius Kabi Ketorolac Injection Product Portfolio
- 13.2.3 Fresenius Kabi Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Fosun Pharma (Gland Pharma)
- 13.3.1 Fosun Pharma (Gland Pharma) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
- 13.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Sagent Pharmaceuticals
- 13.4.1 Sagent Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
- 13.4.3 Sagent Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Hikma
- 13.5.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Hikma Ketorolac Injection Product Portfolio
- 13.5.3 Hikma Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Lunan Pharma
- 13.6.1 Lunan Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Lunan Pharma Ketorolac Injection Product Portfolio
- 13.6.3 Lunan Pharma Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Alvogen
- 13.7.1 Alvogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Alvogen Ketorolac Injection Product Portfolio
- 13.7.3 Alvogen Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Chengdu Brilliant Pharmaceuticals
- 13.8.1 Chengdu Brilliant Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
- 13.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Athenex
- 13.9.1 Athenex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Athenex Ketorolac Injection Product Portfolio
- 13.9.3 Athenex Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Sichuan Medcalo
- 13.10.1 Sichuan Medcalo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Sichuan Medcalo Ketorolac Injection Product Portfolio
- 13.10.3 Sichuan Medcalo Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Julphar Bangladesh Ltd.
- 13.11.1 Julphar Bangladesh Ltd. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
- 13.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Yung Shin Pharm
- 13.12.1 Yung Shin Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Yung Shin Pharm Ketorolac Injection Product Portfolio
- 13.12.3 Yung Shin Pharm Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Tianjin Chase Sun Pharmaceutical
- 13.13.1 Tianjin Chase Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
- 13.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 ZISKA Pharmaceuticals
- 13.14.1 ZISKA Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
- 13.14.3 ZISKA Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Ketorolac Injection Industry Chain Analysis
- 14.2 Ketorolac Injection Industry Raw Material and Suppliers Analysis
- 14.2.1 Ketorolac Injection Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Ketorolac Injection Typical Downstream Customers
- 14.4 Ketorolac Injection Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
